. En, . Méthode, and . Bucher, En violet : Méta-analyse en réseau (MTC) En vert : positif. En rouge : négatif

. Direction-de-la-sécurité-sociale, Les Comptes de la Sécurité Sociale -Rapport -Résultats 2013, 2014.

H. Autorité and D. Santé, Rapport de synthèse. Les comparaisons indirectes : Méthodes et validités, 2009.

G. Wells, Indirect Evidence: Indirect Treatment Comparisons in Meta-Analysis. Canadian Agency for Drugs and Technologies in Health, 2009.

J. Jansen, T. Trikalinos, and J. Cappelleri, Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report, Value in Health, vol.17, issue.2, pp.157-73, 2014.
DOI : 10.1016/j.jval.2014.01.004

A. Glenny, D. Altman, and F. Song, Indirect comparisons of competing interventions, Health Technology Assessment, vol.9, issue.26, 2005.
DOI : 10.3310/hta9260

F. Song, Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses, BMJ, vol.326, issue.7387, pp.472-472, 2003.
DOI : 10.1136/bmj.326.7387.472

H. Bucher, G. Guyatt, L. Griffith, and S. Walter, The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials, Journal of Clinical Epidemiology, vol.50, issue.6, pp.683-91, 1997.
DOI : 10.1016/S0895-4356(97)00049-8

J. Higgins and S. Green, Cochrane handbook for systematic reviews of interventions Wiley Online Library, 2008.

F. Song, What is indirect comparison, 2009.

D. Caldwell, A. Ades, and J. Higgins, Simultaneous comparison of multiple treatments: combining direct and indirect evidence, BMJ, vol.331, issue.7521, pp.897-900, 2005.
DOI : 10.1136/bmj.331.7521.897

G. Lu and A. Ades, Combination of direct and indirect evidence in mixed treatment comparisons, Statistics in Medicine, vol.48, issue.20, pp.3105-3129, 2004.
DOI : 10.1002/sim.1875

P. Moayyedi, S. Soo, J. Deeks, B. Delaney, M. Innes et al., Pharmacological interventions for non-ulcer dyspepsia, Cochrane Database Syst Rev, p.1960, 2006.

T. Evelinda, M. Devidas, C. Assessment, H. For, and B. Jean-françois, Selective Serotonin Reuptake Inhibitors (SSRIs) for Major Depression. Canadian Coordinating Office for Health Technology Assessment, 1997.

T. Lumley, Network meta-analysis for indirect treatment comparisons, Statistics in Medicine, vol.29, issue.16, pp.2313-2337, 2002.
DOI : 10.1002/sim.1201

G. Salanti, J. Higgins, A. Ades, and J. Ioannidis, Evaluation of networks of randomized trials, Statistical Methods in Medical Research, vol.21, issue.11, pp.279-301, 2008.
DOI : 10.1177/0962280207080643

A. Cipriani, J. Higgins, J. Geddes, and G. Salanti, Conceptual and Technical Challenges in Network Meta-analysis, Annals of Internal Medicine, vol.159, issue.2, pp.130-137, 2013.
DOI : 10.7326/0003-4819-159-2-201307160-00008

W. Elliott and P. Meyer, Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis, The Lancet, vol.369, issue.9557, pp.201-208, 2007.
DOI : 10.1016/S0140-6736(07)60108-1

S. Goodman, Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy, Annals of Internal Medicine, vol.130, issue.12, pp.995-1004, 1999.
DOI : 10.7326/0003-4819-130-12-199906150-00008

R. Van-der-valk, C. Webers, T. Lumley, F. Hendrikse, M. Prins et al., A network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressure, Journal of Clinical Epidemiology, vol.62, issue.12, pp.1279-83, 2009.
DOI : 10.1016/j.jclinepi.2008.04.012

B. Psaty, T. Lumley, and C. Furberg, Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents, JAMA, vol.289, issue.19, pp.2534-2578, 2003.
DOI : 10.1001/jama.289.19.2534

H. Jeffreys, The theory of probability, pp.9-9, 1998.

J. Bernardo and A. Smith, Bayesian Theory, 2009.
DOI : 10.1002/9780470316870

D. Spiegelhalter, K. Abrams, and J. Myles, Bayesian Approaches to Clinical Trials and Health-Care Evaluation, 2004.
DOI : 10.1002/0470092602

A. Sutton, K. Abrams, D. Jones, D. Jones, T. Sheldon et al., Methods for meta- analysis in medical research, 2000.

K. Abrams, J. Myles, and D. Spiegelhalter, Bayesian approaches to clinical trials and health- care evaluation, 2004.

G. Salanti, A. Ades, and J. Ioannidis, Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial, Journal of Clinical Epidemiology, vol.64, issue.2, pp.163-71, 2011.
DOI : 10.1016/j.jclinepi.2010.03.016

A. Cipriani, C. Barbui, and G. Salanti, Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis, The Lancet, vol.378, issue.9799, pp.1306-1321, 2011.
DOI : 10.1016/S0140-6736(11)60873-8

J. Sterne, M. Egger, and D. Moher, Addressing Reporting Biases, Cochrane Handb Syst Rev Interv Cochrane Book Ser, pp.297-333, 2008.
DOI : 10.1002/9780470712184.ch10

S. Aaron, D. Fergusson, and G. Marks, Counting, analysing and reporting exacerbations of COPD in randomised controlled trials, Thorax, vol.63, issue.2, pp.122-130, 2008.
DOI : 10.1136/thx.2007.082636

E. Mills, E. Druyts, I. Ghement, and M. Puhan, Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis, Clinical Epidemiology, vol.3, pp.107-136, 2011.
DOI : 10.2147/CLEP.S16235

L. Eckert, La méta-régression comme méthodologie de comparaisons indirectes : une réponse aux éxigences contemporaines de l'évaluation du médicament, Paris, vol.11, 2007.

S. Thompson and J. Higgins, How should meta-regression analyses be undertaken and interpreted?, Statistics in Medicine, vol.315, issue.11, pp.1559-73, 2002.
DOI : 10.1002/sim.1187

C. Schmid, P. Stark, J. Berlin, P. Landais, and J. Lau, Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors, Journal of Clinical Epidemiology, vol.57, issue.7, pp.683-97, 2004.
DOI : 10.1016/j.jclinepi.2003.12.001

N. Cooper, A. Sutton, D. Morris, A. Ades, and N. Welton, Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation, Statistics in Medicine, vol.25, issue.15, pp.1861-81, 2009.
DOI : 10.1002/sim.3594

G. Salanti, V. Marinho, and J. Higgins, A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered, Journal of Clinical Epidemiology, vol.62, issue.8, pp.857-64, 2009.
DOI : 10.1016/j.jclinepi.2008.10.001

S. Dias, N. Welton, V. Marinho, G. Salanti, J. Higgins et al., Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta-analysis, Journal of the Royal Statistical Society: Series A (Statistics in Society), vol.336, issue.3, pp.613-642, 2010.
DOI : 10.1111/j.1467-985X.2010.00639.x

M. Coory and S. Jordan, Frequency of Treatment-Effect Modification Affecting Indirect Comparisons, PharmacoEconomics, vol.31, issue.9, pp.723-755, 2010.
DOI : 10.2165/11535670-000000000-00000

E. Mills, P. Wu, and G. Chong, Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials, QJM, vol.104, issue.2, pp.109-133, 2011.
DOI : 10.1093/qjmed/hcq165

J. Berlin, J. Santanna, C. Schmid, L. Szczech, and H. Feldman, Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head, Statistics in Medicine, vol.273, issue.3, pp.371-87, 2002.
DOI : 10.1002/sim.1023

F. Song, Y. Loke, T. Walsh, A. Glenny, A. Eastwood et al., Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews, BMJ, vol.338, issue.apr03 1, 2009.
DOI : 10.1136/bmj.b1147

J. Higgins, S. Thompson, J. Deeks, and D. Altman, Measuring inconsistency in meta-analyses, BMJ, vol.327, issue.7414, pp.557-60, 2003.
DOI : 10.1136/bmj.327.7414.557

A. Ades, G. Lu, and J. Higgins, The Interpretation of Random-Effects Meta-Analysis in Decision Models, Medical Decision Making, vol.25, issue.6, pp.646-54, 2005.
DOI : 10.1177/0272989X05282643

F. Song, I. Harvey, and R. Lilford, Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions, Journal of Clinical Epidemiology, vol.61, issue.5, pp.455-63, 2008.
DOI : 10.1016/j.jclinepi.2007.06.006

S. Dias, A. Sutton, A. Ades, and N. Welton, Evidence Synthesis for Decision Making 2, Medical Decision Making, vol.14, issue.5, pp.607-624, 2013.
DOI : 10.3310/hta10460

E. Mills, J. Ioannidis, K. Thorlund, H. Schünemann, M. Puhan et al., How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis, JAMA, vol.308, issue.12, pp.1246-53, 2012.
DOI : 10.1001/2012.jama.11228

S. Dias, N. Welton, D. Caldwell, and A. Ades, Checking consistency in mixed treatment comparison meta-analysis, Statistics in Medicine, vol.172, issue.15, pp.932-976, 2010.
DOI : 10.1002/sim.3767

G. Lu and A. Ades, Assessing Evidence Inconsistency in Mixed Treatment Comparisons, Journal of the American Statistical Association, vol.101, issue.474, pp.447-59, 2006.
DOI : 10.1198/016214505000001302

F. Song, T. Xiong, and S. Parekh-bhurke, Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study, BMJ, vol.343, issue.aug16 2, pp.4909-4909, 2011.
DOI : 10.1136/bmj.d4909

W. Zhang, L. W. Po, and A. , Analgesic efficacy of paracetamol and its combination with codeine and caffeine in surgical pain-a meta-analysis, Journal of Clinical Pharmacy and Therapeutics, vol.6, issue.Suppl., pp.261-82, 1996.
DOI : 10.1111/j.1365-2710.1996.tb01148.x

A. Khan, S. Khan, R. Leventhal, and W. Brown, Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database, The International Journal of Neuropsychopharmacology, vol.4, issue.02, pp.113-121, 2001.
DOI : 10.1017/S1461145701002322

I. Kirsch, T. Moore, A. Scoboria, and S. Nicholls, The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration, Prev Treat, vol.5, 2002.

J. Williams, C. Mulrow, E. Chiquette, P. Noël, C. Aguilar et al., A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2, Annals of Internal Medicine, vol.132, issue.9, pp.743-56, 2000.
DOI : 10.7326/0003-4819-132-9-200005020-00011

A. Cipriani, T. Furukawa, and G. Salanti, Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, The Lancet, vol.373, issue.9665, pp.746-58, 2009.
DOI : 10.1016/S0140-6736(09)60046-5

E. Turner, A. Matthews, E. Linardatos, R. Tell, and R. Rosenthal, Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy, New England Journal of Medicine, vol.358, issue.3, pp.252-60, 2008.
DOI : 10.1056/NEJMsa065779

J. Ioannidis, Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?, Philosophy, Ethics, and Humanities in Medicine, vol.3, issue.1, p.14, 2008.
DOI : 10.1186/1747-5341-3-14

J. Higgins and A. Whitehead, BORROWING STRENGTH FROM EXTERNAL TRIALS IN A META-ANALYSIS, Statistics in Medicine, vol.15, issue.24
DOI : 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0

J. Ioannidis, Ranking antidepressants, The Lancet, vol.373, issue.9677, pp.1759-60, 2009.
DOI : 10.1016/S0140-6736(09)60974-0

G. Gartlehner, R. Hansen, and L. Morgan, Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder, Annals of Internal Medicine, vol.155, issue.11, pp.772-85, 2011.
DOI : 10.7326/0003-4819-155-11-201112060-00009

J. Jansen, R. Fleurence, and B. Devine, Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1, Value in Health, vol.14, issue.4, pp.417-445, 2011.
DOI : 10.1016/j.jval.2011.04.002

M. Kyrgiou, G. Salanti, N. Pavlidis, E. Paraskevaidis, and J. Ioannidis, Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments, JNCI Journal of the National Cancer Institute, vol.98, issue.22, pp.1655-63, 2006.
DOI : 10.1093/jnci/djj443

K. Dwan, C. Gamble, R. Kolamunnage-dona, S. Mohammed, C. Powell et al., Assessing the potential for outcome reporting bias in a review: a tutorial, Trials, vol.129, issue.6, p.52, 2010.
DOI : 10.1016/S0022-3476(96)70023-9

A. Liberati, D. Altman, and J. Tetzlaff, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, Ann Intern Med, vol.151, p.65, 2009.

S. Leucht, A. Cipriani, and L. Spineli, Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis, The Lancet, vol.382, issue.9896, pp.951-62, 2013.
DOI : 10.1016/S0140-6736(13)60733-3

J. Higgins, D. Altman, and P. Gøtzsche, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, vol.343, issue.oct18 2, 2011.
DOI : 10.1136/bmj.d5928

A. Jadad, R. Moore, and D. Carroll, Assessing the quality of reports of randomized clinical trials: Is blinding necessary?, Controlled Clinical Trials, vol.17, issue.1, pp.1-12, 1996.
DOI : 10.1016/0197-2456(95)00134-4

G. Salanti, F. Kavvoura, and J. Ioannidis, Exploring the Geometry of Treatment Networks, Annals of Internal Medicine, vol.148, issue.7, pp.544-53, 2008.
DOI : 10.7326/0003-4819-148-7-200804010-00011

D. Spiegelhalter, J. Myles, D. Jones, and K. Abrams, Bayesian methods in health technology assessment: a review, Core Research, vol.21, p.38, 2000.

L. Sung, J. Hayden, M. Greenberg, G. Koren, B. Feldman et al., Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study, Journal of Clinical Epidemiology, vol.58, issue.3, pp.261-269, 2005.
DOI : 10.1016/j.jclinepi.2004.08.010

E. Pullenayegum, Q. Guo, S. Hamilton, and R. Hopkins, Developing critical thinking about reporting of Bayesian analyses, J Stat Educ, vol.20, p.1, 2012.

G. Gartlehner, L. Morgan, and P. Thieda, Drug Class Review: Second Generation Antidepressants: Final Report Update 4, p.21089243, 2008.

E. Mills, K. Thorlund, and N. Bansback, Multiple treatment meta-analysis in rheumatoid arthritis can provide weak inferences due to methodological approaches, 2012.

G. Bouvenot, M. Vray, and F. Vicari, ESSAIS cliniques ??? Th??orie, pratique et critique, Acta Endoscopica, vol.36, issue.3, pp.375-375, 2006.
DOI : 10.1007/BF03006053

A. Sylvain, Intégration de l'évaluation médico-économique des médicaments en France au sein de la HAS : impact sur l'accès et le maintien des médicaments sur le marché français, 2014.

G. Bouvenot, Le rôle de la Commission de la transparence de la HAS dans la pertinence de l'admission au remboursement des médicaments par l'Assurance maladie. Regards Numéro 44, 2013.

. Loi, relative au renforcement de la sécurité sanitaire du médicament et des produits de santé, 2011.

C. Chapple, V. Khullar, Z. Gabriel, D. Muston, C. Bitoun et al., The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis, European Urology, vol.54, issue.3, pp.543-62, 2008.
DOI : 10.1016/j.eururo.2008.06.047

C. Chapple, V. Khullar, Z. Gabriel, and J. Dooley, The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis, European Urology, vol.48, issue.1, pp.5-26, 2005.
DOI : 10.1016/j.eururo.2005.02.024

H. Scholz, C. Trenkwalder, R. Kohnen, D. Riemann, L. Kriston et al., Dopamine agonists for the treatment of restless legs syndrome, Cochrane Database Syst Rev, vol.7, issue.2, p.6009, 2011.
DOI : 10.1002/14651858.CD006009.pub2

M. Hornyak, C. Trenkwalder, R. Kohnen, and H. Scholz, Efficacy and safety of dopamine agonists in restless legs syndrome, Sleep Medicine, vol.13, issue.3, pp.228-264, 2012.
DOI : 10.1016/j.sleep.2011.09.013

F. Mickael, B. J. Drummond, G. L. O-'brien, G. W. Stoddart, and . Torrance, Méthodes d'évaluation économique des programmes de santé, 1998.

J. Marine and . Lopez-alain, Evaluation médico-économique en santé, Rapport IGAS

H. Autorité and D. Santé, Décision n°2013.0111/DC/SEESP du 18 septembre 2013 du collège de la Haute Autorité de santé relatif à l'impact significatif sur les dépenses de l'assurance maladie déclenchant l'évaluation médico-économique des produits revendiquant une ASMR ou une ASA de niveaux I, II ou III

H. Autorité and D. Santé, Choix méthodologiques pour l'évaluation économique à la HAS, 2011.

H. Autorité and D. Santé, Valeurs de références pour l'évaluation économique en santé Revue de la littérature, 2014.

. News, La Ceesp favorable à plusieurs évolutions de l'évaluation médicoéconomique des produits de santé, 2014.

H. Autorité and D. Santé, Dépistage de l'infection par le VIH en France Stratégies et dispositifs de dépistage, 2009.

S. Goodacre, J. Nicholl, and S. Dixon, Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care, BMJ, vol.328, issue.7434, p.254, 2004.
DOI : 10.1136/bmj.37956.664236.EE

A. Briggs, O. Brien, B. Blackhouse, and G. , Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies, Annual Review of Public Health, vol.23, issue.1, pp.377-401, 2002.
DOI : 10.1146/annurev.publhealth.23.100901.140534

A. Laws, R. Kendall, and N. Hawkins, A Comparison of National Guidelines for Network Meta-Analysis, Value in Health, vol.17, issue.5, pp.642-54, 2014.
DOI : 10.1016/j.jval.2014.06.001

. Eunethta, Methodological guideline for REA of pharmaceuticals: Direct and indirect comparison, 2013.

J. Jansen and H. Naci, Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers, BMC Medicine, vol.31, issue.1, p.159, 2013.
DOI : 10.1002/sim.5442

D. Hoaglin, N. Hawkins, and J. Jansen, Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2, Value in Health, vol.14, issue.4, pp.429-466, 2011.
DOI : 10.1016/j.jval.2011.01.011